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Diacylglycerol lipases (DAGL) produce the endocannabinoid
2-arachidonoylglycerol, a key modulator of neurotransmitter
release. Chemical tools that visualize endogenous DAGL activity
are desired. Here, we report the design, synthesis and application
of a triazole urea probe for DAGL equipped with a norbornene as a
biorthogonal handle. The activity and selectivity of the probe was
assessed with activity-based protein profiling. This probe was
potent against endogenous DAGLα (IC50 = 5 nM) and it was suc-
cessfully applied as a two-step activity-based probe for labeling of
DAGLα using an inverse electron-demand Diels–Alder ligation in
living cells.
Introduction
Endocannabinoids are key regulators of neurotransmitter
release in the central nervous system (CNS). They are involved
in virtually every aspect of brain function, including modu-
lation of synaptic plasticity and (patho)physiological processes,
such as anxiety, fear and neuroinflammation.1
2-Arachidonoylglycerol (2-AG) is one of the most important
endocannabinoids and activates the cannabinoid CB1 and CB2
receptors. 2-AG is synthesized by two diacylglycerol lipases
(DAGLα (120 kDa) and DAGLβ (70 kDa)).2 Both enzymes
belong to the family of serine hydrolases, which share the
same catalytic Ser-His-Asp triad to hydrolyse the sn-1 ester of
1-acyl-2-arachidonoylglycerides to generate 2-AG. A method to
measure endogenous DAGL activity in biological samples is
therefore important to understand endocannabinoid
physiology.
Activity-based protein profiling (ABPP) is a powerful tech-
nique for monitoring enzyme activity in living systems using
chemical probes.3 These activity-based probes (ABPs) co-
valently and irreversibly bind to the active site of an enzyme
and this interaction can be subsequently monitored using
different techniques depending on the reporter group.4 Several
fluorescent ABPs have been reported to study the two isoforms
of DAGLs. For example, HT-01 (Fig. 1), a DAGL probe based on
1,2,3-triazole urea inhibitors developed by the Cravatt labora-
tory, was used to study endogenous DAGLβ in (primary)
macrophages.5 In addition, DH379, based on the potent DAGL
inhibitor DH376 (Fig. 1), was developed as a tailored fluo-
rescent probe for DAGLα and DAGLβ.6,7 However, reporter
groups may affect the affinity and selectivity of the probes as
well as cell permeability, metabolic stability, protein binding,
oral bioavailability, brain penetration and toxicity. These
issues are avoided by two-step probes in which ligation of the
reporter group to the probe after covalent binding of the
target. Bioorthogonal chemistry enables the design of chemi-
cal probes with a minimalist handle for the conjugation of a
reporter group after the probe target has been bound.8 These
two-step bioorthogonal probes also provide flexibility, as
different reporter groups can be attached to the same probe.
Different pairs of bioorthogonal reactants are currently avail-
able.9 For two-step activity-based probes, the most popular
pair is the azide–alkyne couple. These handles are reacted
Fig. 1 Design of two-step labeling probe 1 based on HT-01 and DH376.
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using the copper-catalyzed azide–alkyne clycloaddition
(CuAAC), often called “click” reaction. Both azides and alkynes
are compact handles, chemically stable and synthetically acces-
sible. An example of a two-step bioorthogonal probe for DAGL
is DH376, which carries an alkyne handle.
The CuAAC is relatively slow and requires toxic Cu(I) as a
catalyst, therefore the inverse electron-demand Diels–Alder
(IEDDA) ligation is sometimes used as an alternative.9 The
reactants are an electron-rich dienophile, such as a norbornene,
and electron poor diene, usually a tetrazine. Tetrazines attached
to fluorophores can serve as both the bioorthogonal reactive
group and the fluorescence quencher, creating fluorescence
“turn-on” reporters ideal for imaging.10,11 An additional advan-
tage is that no catalyst is required for the IEDDA.
We here report the synthesis and characterization of two-
step ABP 1 equipped with a norbornene (Fig. 1) to study its




N-Boc-cadaverine (2) was first nosylated and reacted with phe-
nethyl bromide to yield 3 (Scheme 1). The Boc-group of 3 was
removed with acid to yield 4, which was coupled to the acti-
vated norbornene ester 5 to give the amide 6 as the endo-
isomer. Removal of the nosyl group yielded amine 7.
A Grignard reaction on ester 8 yielded triazole 9. With the
triazole 9 and amine 7 in hand, the final compound 1 was
obtained using a triphosgene coupling.14 Generally, this yields
two regioisomers: N1 and N2. To assign the separate com-
pounds as either N1-regioisomer or N2-regioisomer, it was
anticipated that the NMR chemical shift of the triazole carbon
could be used (ESI: Tables 1 and 2†). To this end, theoretical
chemical shifts were computed with density functional theory
(DFT) for simplified structures of the triazole urea scaffold
(ESI: Table 1†). The chemical shift in DMSO was calculated for
the lowest energy conformer of either the N1 or N2 regio-
isomer. This resulted in theoretical chemical shift differences
of approximately 10 ppm between the triazole carbon of the
N1 regiosiomer (±125 ppm) and N2 regioisomer (±135 ppm).
In addition, the triazole proton is highly characteristic (broad,
downfield peak) and HSQC experiments were used to confi-
dently assign the triazole carbon peak in the 13C aromatic
region. Therefore, we synthesized and analyzed reference com-
pounds (11–13, 22–24, ESI: Fig. 1, Schemes 1 and 2, Tables 1
and 2†). The assignment of the reference isomers was in agree-
ment with earlier reported triazole ureas as determined with a
crystal structure or NMR measurements. Thus, this analysis
allowed us to assign ABP 1 as a N2 regioisomer.
Biochemical analysis
The potency and selectivity of probe 1 was profiled in mouse
brain proteome using ABPP with MB064, FP-TAMRA and
DH379 as chemical probes (Fig. 2). Probe 1 showed a dose-
dependent inhibition of DAGLα and DAGLβ with a pIC50 of
8.3 ± 0.3 and 8.6 ± 0.1, respectively (Fig. 2b and d) In addition,
in situ experiments were performed with probe 1 (Fig. 2e)
using the human cell line U2OS transiently transfected with
recombinant human DAGLα. Live cells were treated with 1 and
post-lysis labeled with MB064. Probe 1 was able to cross the
cell membrane and label human DAGLα, albeit with a ten-fold
lower potency compared to in vitro mouse brain proteome
(Fig. 2f). Of note, probe 1 also inhibited the post-lysis labeling
of endogenous α,β-hydrolase domain containing enzyme
(ABHD6) (Fig. 2e, the band around 35 kDa) with a pIC50 of 8.5
± 0.3 (Fig. 2f). This discrepancy between in situ and in vitro
potency has been previously observed for other covalent, irre-
versible serine hydrolase inhibitors.6,15
To test if our norbornene probe 1 reacted with tetrazine 10
(See ESI†) via the expected IEDDA mechanism, the reaction
Scheme 1 Synthesis of probe 1. Reagents and conditions: (a) i. NsCl, Et3N, THF; ii. Ph(CH2)2Br, Cs2CO3, CH3CN, 80 °C, 92%; (b) TFA/DCM 1 : 9,
100%; (c) DIPEA, DMF, 33%. (d) PhSH, Cs2CO3, CH3CN, 41%; (e) 4-fluorophenylmagnesium bromide, THF, 74%; (f ) i. triphosgene, DIPEA, THF, 0 °C; ii.
9, DIPEA, DMAP, THF, 60 °C, 37%.
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products were analyzed by LC-MS. The mass of the proton
adduct of the expected reaction products was observed (ESI:
Fig. 3†).
Next, the toxicity of probe 1 to living cells was evaluated
and compared to existing probes HT-01 and DH376. U2OS
cells were treated with each probe separately and a live cell
count was performed (Fig. 3). Under the conditions tested,
none of the probes were toxic to cells. To evaluate the toxicity
Fig. 2 Activity-based protein profiling of probe 1 in mouse brain membrane proteome against (a) MB064 and FP-TAMRA and (c) DH379. (b)
Quantification of residual DAGLα activity as measured with MB064 in mouse brain. (d) Quantification of residual DAGLα and DAGLβ activity as
measured with DH379 in mouse brain. (e) In situ treatment with 1 of U2OS cells transfected with DAGLα. (f ) Quantification of residual DAGLα and
ABHD6 activity as measured with MB064 in U2OS-DAGLα cells.
Fig. 3 Cell survival of wildtype U2OS, treated for 1 h at 37 °C with:
probe 1 (5 µM), BODIPY-tetrazine 10 (10 µM), probe HT-01 (1 µM),
DH376 (1 µM), or ClickMix.
Fig. 4 In situ labeling of recombinant DAGLα expressed in U2OS with
direct probe HT-01 (1 µM), probe 1 (5 µM) with BODIPY-tetrazine 10
(10 µM), and competition between probe 1 (5 µM) and HT-01 (1 µM). All
treatments: 1 h in situ at 37 °C. Western blot (anti-FLAG) is shown as a
protein expression control, Coomassie staining is shown as a loading
control.
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of two-step labeling in living cells, tetrazine 10 was also tested
and appeared to be non-toxic. Cells also survived the combi-
nation of probe 1 and tetrazine 10 treatment. For the CuAAC
reaction conditions however (ClickMix alone or with DH376),
almost 75% of the treated cells died within 1 h. This result
illustrates the advantages of IEDDA chemistry compared to
CuAAC for live cell labeling experiments.
Finally, in situ two-step labeling was performed with fluoro-
genic BODIPY-tetrazine 10 (Fig. 4).11 U2OS cells were trans-
fected with either human DAGLα, catalytically inactive
DAGLαS472A or a mock control. The two-step labeling was
compared to direct labeling with probe HT-01, which resulted
in a strong fluorescent band just below 130 kDa, which was
absent in the DAGLαS472A and mock controls. Pre-treatment of
the cells with probe 1 partially blocked the labeling with
HT-01, suggesting probe 1 does not fully inhibit DAGLα.
Treatment with norbornene probe 1, followed by in situ treat-
ment with tetrazine 10 resulted in partial labeling of DAGLα,
which was absent in the DAGLαS472A and mock controls.
Treatment of cells expressing DAGLα with tetrazine 10 showed
some background labeling. The background labeling pattern
in the DAGLαS472A and mock controls was similar. In
conclusion, norbornene probe 1 reacted to the catalytic serine
of DAGLα in live cells and can be labeled with a tetrazine
fluorophore, but its fluorescent signal is weaker compared to
labeling with direct probe HT-01, which might be due to a
difference in the fluorescent reporter group and/or the
efficiency of labeling.
Conclusions
Norbornene probe 1 was successfully synthesized as a two-step
ABP for labeling of DAGLα using an IEDDA ligation in living
cells and compared to a click reaction and direct probe HT-01.
The IEDDA reaction is complementary to the CuAAC reaction
for labeling DAGLα, but is preferred for in situ imaging of
enzyme activity (due to its low cellular toxicity).16 However, the
labeling efficiency of direct probe HT-01 is higher than the
two-step probe 1. Therefore, additional probes with improved
activity and bioorthogonal handles with faster reaction rates
should be made to study endogenous DAGL activity. For live
cell imaging, fluorogenic tetrazines with longer wavelengths
than 10 are required.17 It is envisioned that live cell imaging of
DAGL activity will enable the study of this endocannabinoid
enzyme’s localization and processing during differentiation
and other cellular processes.
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